Published in J Clin Oncol on February 01, 2001
ABC transporters: unvalidated therapeutic targets in cancer and the CNS. Anticancer Agents Med Chem (2010) 1.05
A pharmacodynamic study of docetaxel in combination with the P-glycoprotein antagonist tariquidar (XR9576) in patients with lung, ovarian, and cervical cancer. Clin Cancer Res (2010) 1.04
Methods to evaluate biliary excretion of drugs in humans: an updated review. Mol Pharm (2006) 0.98
The influence of P-glycoprotein expression and its inhibitors on the distribution of doxorubicin in breast tumors. BMC Cancer (2009) 0.95
Phase I study of valspodar (PSC-833) with mitoxantrone and etoposide in refractory and relapsed pediatric acute leukemia: a report from the Children's Oncology Group. Pediatr Blood Cancer (2010) 0.83
Phase I study of pegylated liposomal doxorubicin and the multidrug-resistance modulator, valspodar. Br J Cancer (2005) 0.81
Effect of valspodar on the pharmacokinetics of unbound paclitaxel. Invest New Drugs (2003) 0.78
P-glycoprotein mediated drug interactions in animals and humans with cancer. J Vet Intern Med (2015) 0.78
A population pharmacokinetic model for paclitaxel in the presence of a novel P-gp modulator, Zosuquidar Trihydrochloride (LY335979). Br J Clin Pharmacol (2003) 0.76
The strong in vivo anti-tumor effect of the UIC2 monoclonal antibody is the combined result of Pgp inhibition and antibody dependent cell-mediated cytotoxicity. PLoS One (2014) 0.75
Biodegradable mixed MPEG-SS-2SA/TPGS micelles for triggered intracellular release of paclitaxel and reversing multidrug resistance. Int J Nanomedicine (2016) 0.75
The sequence of the human genome. Science (2001) 101.55
The genome sequence of Drosophila melanogaster. Science (2000) 74.32
An information-intensive approach to the molecular pharmacology of cancer. Science (1997) 11.43
Compilation of tRNA sequences and sequences of tRNA genes. Nucleic Acids Res (1998) 10.74
Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: recommendations from the Prostate-Specific Antigen Working Group. J Clin Oncol (1999) 9.22
Heterogeneities in the transmission of infectious agents: implications for the design of control programs. Proc Natl Acad Sci U S A (1997) 9.07
The Resistance of the Red Blood Corpuscles of the Horse to Salt Solutions of different Tonicities before and after repeated Withdrawals of Blood. J Med Res (1906) 8.07
Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Nat Genet (1997) 6.83
Comparison of the complete protein sets of worm and yeast: orthology and divergence. Science (1998) 6.28
Characterization of a "silencer" in yeast: a DNA sequence with properties opposite to those of a transcriptional enhancer. Cell (1985) 6.23
The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2. EMBO J (1998) 6.08
The Agglutination Affinities of related Bacteria Parasitic in different Hosts. J Med Res (1903) 6.06
Paclitaxel-resistant human ovarian cancer cells have mutant beta-tubulins that exhibit impaired paclitaxel-driven polymerization. J Biol Chem (1997) 5.51
Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nat Genet (2000) 5.50
Prediction of gene structure. J Mol Biol (1992) 5.31
A Study of Streptococci isolated from certain presumably milk-borne Epidemics of Tonsillitis occurring in Massachusetts in 1913 and 1914. J Med Res (1915) 5.06
Randomised trial of efficacy of SPf66 vaccine against Plasmodium falciparum malaria in children in southern Tanzania. Lancet (1994) 5.06
STUDIES ON A PARATYPHOID INFECTION IN GUINEA PIGS : I. REPORT OF A NATURAL OUTBREAK OF PARATYPHOID IN A GUINEA PIG POPULATION. J Exp Med (1927) 5.01
Localization and sequence analysis of yeast origins of DNA replication. Cold Spring Harb Symp Quant Biol (1983) 4.85
p14ARF links the tumour suppressors RB and p53. Nature (1998) 4.78
Clarithromycin therapy for bacteremic Mycobacterium avium complex disease. A randomized, double-blind, dose-ranging study in patients with AIDS. AIDS Clinical Trials Group Protocol 157 Study Team. Ann Intern Med (1994) 4.74
A fundamental division in the Alu family of repeated sequences. Proc Natl Acad Sci U S A (1988) 4.63
Compilation of tRNA sequences and sequences of tRNA genes. Nucleic Acids Res (1996) 4.31
PRODUCTION OF FATAL BLACKHEAD IN TURKEYS BY FEEDING EMBRYONATED EGGS OF HETERAKIS PAPILLOSA. J Exp Med (1920) 4.29
Fluoxetine in the treatment of premenstrual dysphoria. Canadian Fluoxetine/Premenstrual Dysphoria Collaborative Study Group. N Engl J Med (1995) 3.92
Exaggerated neuroinflammation and sickness behavior in aged mice following activation of the peripheral innate immune system. FASEB J (2005) 3.84
Regulation of mating-type information in yeast. Negative control requiring sequences both 5' and 3' to the regulated region. J Mol Biol (1984) 3.56
Long-term outcome for children with autism who received early intensive behavioral treatment. Am J Ment Retard (1993) 3.40
Opioid-induced respiratory depression in paediatrics: a review of case reports. Br J Anaesth (2012) 3.39
2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol (2001) 3.25
Nonsteroidal antiinflammatory drug-induced intestinal inflammation in humans. Gastroenterology (1987) 3.24
Sequence of the lon gene in Escherichia coli. A heat-shock gene which encodes the ATP-dependent protease La. J Biol Chem (1988) 3.21
AA2500 testosterone gel normalizes androgen levels in aging males with improvements in body composition and sexual function. J Clin Endocrinol Metab (2003) 3.19
NHS: a time to choose. BMJ (1989) 3.19
The reliability of diagnostic techniques in the diagnosis and management of malaria in the absence of a gold standard. Lancet Infect Dis (2006) 3.19
p53 is associated with cellular microtubules and is transported to the nucleus by dynein. Nat Cell Biol (2000) 3.05
A population of fast radio bursts at cosmological distances. Science (2013) 3.03
Medical audit. BMJ (1990) 3.00
Suramin: a novel growth factor antagonist with activity in hormone-refractory metastatic prostate cancer. J Clin Oncol (1992) 3.00
Impact of spatial distribution of permethrin-impregnated bed nets on child mortality in rural northern Ghana. Am J Trop Med Hyg (1998) 2.95
What is clinical malaria? Finding case definitions for field research in highly endemic areas. Parasitol Today (1994) 2.90
An update of recent evidence of the relationship between objective and self-report measures of the physical environment and physical activity behaviours. J Sci Med Sport (2004) 2.90
The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity. Brain (2000) 2.84
BRCA1/BRCA2 germline mutations in locally recurrent breast cancer patients after lumpectomy and radiation therapy: implications for breast-conserving management in patients with BRCA1/BRCA2 mutations. J Clin Oncol (1999) 2.79
BHD mutations, clinical and molecular genetic investigations of Birt-Hogg-Dubé syndrome: a new series of 50 families and a review of published reports. J Med Genet (2008) 2.79
Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes. Cancer Res (1999) 2.70
Bayesian modelling of geostatistical malaria risk data. Geospat Health (2006) 2.69
Tumor necrosis factor/cachectin increases permeability of endothelial cell monolayers by a mechanism involving regulatory G proteins. J Exp Med (1989) 2.69
Birt-Hogg-Dubé syndrome, a genodermatosis associated with spontaneous pneumothorax and kidney neoplasia, maps to chromosome 17p11.2. Am J Hum Genet (2001) 2.68
Oxaliplatin, tetraplatin, cisplatin, and carboplatin: spectrum of activity in drug-resistant cell lines and in the cell lines of the National Cancer Institute's Anticancer Drug Screen panel. Biochem Pharmacol (1996) 2.67
Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene. Hum Mutat (1998) 2.64
Spatial patterns of infant mortality in Mali: the effect of malaria endemicity. Am J Epidemiol (2004) 2.62
Efficacy of new, concise schedule for melarsoprol in treatment of sleeping sickness caused by Trypanosoma brucei gambiense: a randomised trial. Lancet (2000) 2.60
Correlation of the highest-energy cosmic rays with nearby extragalactic objects. Science (2007) 2.57
Appearance of heparin-binding EGF-like growth factor in wound fluid as a response to injury. Proc Natl Acad Sci U S A (1993) 2.51
The development of functional and equivalence classes in high-functioning autistic children: the role of naming. J Exp Anal Behav (1992) 2.48
The pathogenicity of long versus short fibre samples of amosite asbestos administered to rats by inhalation and intraperitoneal injection. Br J Exp Pathol (1986) 2.44
OATP1B1 polymorphism as a determinant of erythromycin disposition. Clin Pharmacol Ther (2012) 2.43
The effect of distance from home on attendance at a small rural health centre in Papua New Guinea. Int J Epidemiol (1998) 2.41
Malaria mapping using transmission models: application to survey data from Mali. Am J Epidemiol (2005) 2.41
Information for patients. BMJ (1992) 2.38
Antibody to Varicella-Zoster virus in parturient women and their offspring during the first year of life. Pediatrics (1976) 2.35
Copy number variations of chromosome 16p13.1 region associated with schizophrenia. Mol Psychiatry (2009) 2.29
Lack of cyclin D-Cdk complexes in Rb-negative cells correlates with high levels of p16INK4/MTS1 tumour suppressor gene product. EMBO J (1995) 2.26
Inhibitor of histone deacetylation, depsipeptide (FR901228), in the treatment of peripheral and cutaneous T-cell lymphoma: a case report. Blood (2001) 2.25
The epidemiology of malaria in the Wosera area, East Sepik Province, Papua New Guinea, in preparation for vaccine trials. I. Malariometric indices and immunity. Ann Trop Med Parasitol (1995) 2.24
Effects of ligand activation of peroxisome proliferator-activated receptor gamma in human prostate cancer. Proc Natl Acad Sci U S A (2000) 2.23
Phase II trial of the antiangiogenic agent thalidomide in patients with recurrent high-grade gliomas. J Clin Oncol (2000) 2.22
The Non-Identity of Agglutinins Acting upon the Flagella and upon the Body of Bacteria. J Med Res (1903) 2.21
Members of the olfactory receptor gene family are contained in large blocks of DNA duplicated polymorphically near the ends of human chromosomes. Hum Mol Genet (1998) 2.21
A common pharmacophore for epothilone and taxanes: molecular basis for drug resistance conferred by tubulin mutations in human cancer cells. Proc Natl Acad Sci U S A (2000) 2.20
Seizure resulting from a venlafaxine overdose. Ann Pharmacother (1997) 2.20
Cancer services. BMJ (1991) 2.13
Specific loss of apoptotic but not cell-cycle arrest function in a human tumor derived p53 mutant. EMBO J (1996) 2.12
Breast-conserving therapy vs mastectomy in early-stage breast cancer: a meta-analysis of 10-year survival. Cancer J Sci Am (1997) 2.09
A comparison of two techniques for ankle jerk assessment in elderly subjects. Lancet (1994) 2.07
Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1-4 mm melanomas. Ann Surg Oncol (2001) 2.06
Propulsion (mass movements) in the human colon and its relationship to meals and somatic activity. Gut (1970) 2.05
Area effects of bednet use in a malaria-endemic area in Papua New Guinea. Trans R Soc Trop Med Hyg (2001) 2.05
Spatial and temporal variation in abundance of Anopheles (Diptera:Culicidae) in a malaria endemic area in Papua New Guinea. J Med Entomol (1997) 2.04
Therapy of advanced prostate cancer with granulocyte macrophage colony-stimulating factor. Clin Cancer Res (1999) 2.02
New year message. Br Med J (Clin Res Ed) (1988) 2.01
Transmission of varicella-vaccine virus from a healthy 12-month-old child to his pregnant mother. J Pediatr (1997) 2.00
Blood and protein loss via small-intestinal inflammation induced by non-steroidal anti-inflammatory drugs. Lancet (1987) 1.99
Differential activation of target cellular promoters by p53 mutants with impaired apoptotic function. Mol Cell Biol (1996) 1.99
Contribution of serum ethanol concentration to the osmol gap: a prospective volunteer study. Clin Toxicol (Phila) (2013) 1.98
Unwanted pregnancies. BMJ (1990) 1.94
Diversity of antigens expressed on the surface of erythrocytes infected with mature Plasmodium falciparum parasites in Papua New Guinea. Am J Trop Med Hyg (1989) 1.94
Sites required for position-effect regulation of mating-type information in yeast. Cold Spring Harb Symp Quant Biol (1983) 1.94
Acyclovir treatment of varicella in otherwise healthy adolescents. The Collaborative Acyclovir Varicella Study Group. J Pediatr (1992) 1.94
p53 inhibits hypoxia-inducible factor-stimulated transcription. J Biol Chem (1998) 1.94
Microtubule-interfering agents activate c-Jun N-terminal kinase/stress-activated protein kinase through both Ras and apoptosis signal-regulating kinase pathways. J Biol Chem (1998) 1.93
Three-year outcomes from BENEFIT, a randomized, active-controlled, parallel-group study in adult kidney transplant recipients. Am J Transplant (2011) 1.93
THE AGGLUTINATING ACTION OF AGAR ON BACTERIA. Science (1931) 1.92
The ORION study: comparison of two sirolimus-based regimens versus tacrolimus and mycophenolate mofetil in renal allograft recipients. Am J Transplant (2011) 1.90
Posttranscriptionally modified nucleosides in transfer RNA: their locations and frequencies. Biochimie (1995) 1.90